These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4992976)

  • 1. Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.
    Dickinson JM; Mitchison DA
    Tubercle; 1970 Mar; 51(1):82-94. PubMed ID: 4992976
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
    Nitti V; Ninni A; Natali P
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):859-70. PubMed ID: 4975183
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental evaluation of the antimycobacterial activity of rifampicin].
    Ninni A; Scoles E; Iodice F; Razza I
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):315-28. PubMed ID: 4981410
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 5. The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
    Dickinson JM
    Scand J Respir Dis Suppl; 1969; 69():91-8. PubMed ID: 4190279
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
    Elghoul MT; Joshi RM; Rizghalla T
    Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin].
    Golychevskaja VI
    G Ital Chemioter; 1972; 19(2):20-2. PubMed ID: 4199029
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tuberculostatic activity of various rifampicin derivatives in vitro and in vivo].
    Kochanova NK; Miakotina EN; Bellendir EN; Boiarkina SK; Iudelevich VI
    Probl Tuberk; 1983 Jun; (6):65-8. PubMed ID: 6410375
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-resistant tuberculosis in Sierra Leone.
    Gibson J
    Tubercle; 1986 Jun; 67(2):119-24. PubMed ID: 3095965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin in experimental investigations on mice.
    Havel A; Adámek L; Simonová S
    Antibiot Chemother; 1970; 16():406-15. PubMed ID: 5002306
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse].
    Grosset J; Truffot-Pernot C; Poggi S; Lecoeur H; Chastang C
    Rev Mal Respir; 1985; 2(4):205-8. PubMed ID: 3937188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of resistance of Mycobacterium tuberculosis to chemoantibiotics].
    Lucchesi M; Zubiani M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1967; 27(3):228-52. PubMed ID: 4972422
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensitivity to rifaximin and rifampicin of Mycobacterium tuberculosis isolated from guinea pigs treated orally with rifaximin.
    Malvisi Stracciari J; Venturini AP; Anfossi P; Marchi E; Stracciari GL
    Chemioterapia; 1987 Apr; 6(2):82-4. PubMed ID: 3109750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activity of Rifampicin associated with other drugs on experimental tuberculosis in guinea pigs].
    Nitti V; Ninni A
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):871-95. PubMed ID: 5304754
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tidsskr Nor Laegeforen; 1975 Jun; 95(17-18):1087-9. PubMed ID: 806991
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.
    Grumbach F; Canetti G; Le Lirzin M
    Tubercle; 1969 Sep; 50(3):280-93. PubMed ID: 4981497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.